Literature DB >> 9884561

[Early hemodynamic effects of olprinone hydrochloride after coronary artery bypass grafting].

A Marui1, T Mochizuki, N Mitsui, T Koyama, M Horibe.   

Abstract

Our purpose was to evaluate the hemodynamic effects of olprinone hydrochloride early after coronary artery bypass grafting (CABG). Fifteen patients undergoing CABG were administered a constant infusion of 0.1 microgram/kg/min of olprinone and continued for 4 hours. No bolus infusion of olprinone was administered before continuous infusion. Systolic systemic arterial pressure, systolic pulmonary arterial pressure, systemic vascular resistance and pulmonary vascular resistance were significantly decreased. There were no significant changes in heart rate, mean central venous pressure, mean left atrial pressure and left ventricular stroke work index. Cardiac index was significantly increased, but a correlation between cardiac index and mixed venous blood oxygen saturation was not found. Double product was significantly decreased, which described above suggest that olprinone achieved improvement of left cardiac function without more myocardial oxygen consumption. Severe transient hypotension (systolic arterial pressure < 80 mmHg) after infusion of olprinone was observed in three patients. Olprinone administered soon after CABG surgery had beneficial effects in terms of improvement of hemodynamic status without more oxygen consumption and reduction of pulmonary vascular resistance. However transient hypotension was a serious clinical problem in patients after open heart surgery, especially in CABG patients who need suitable systolic arterial pressure to keep enough blood perfusion of arterial bypass grafts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884561     DOI: 10.1007/bf03217885

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  7 in total

1.  Effects of amrinone on cardiac index, venous oxygen saturation and venous admixture in patients recovering from cardiac surgery.

Authors:  R C Prielipp; J F Butterworth; G P Zaloga; P G Robertie; R L Royster
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

2.  Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.

Authors:  R G Pozen; R DiBianco; R J Katz; R Bortz; R J Myerburg; R D Fletcher
Journal:  Circulation       Date:  1981-06       Impact factor: 29.690

3.  Tolerance to dobutamine after a 72 hour continuous infusion.

Authors:  D A Unverferth; M Blanford; R E Kates; C V Leier
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

4.  Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure.

Authors:  C Richard; C Thuillez; M Pezzano; G Bottineau; J F Giudicelli; P Auzepy
Journal:  Chest       Date:  1989-06       Impact factor: 9.410

5.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

6.  [Effects of the new cardiotonic agent loprinone hydrochloride (E-1020) on left ventricular diameter in normal and experimental heart failure dogs and its action potential characteristics in isolated guinea pig cardiac muscles and sinus nodes].

Authors:  H Ohhara; K Sawada; T Ogawa; M Takeda; T Igarashi
Journal:  Nihon Yakurigaku Zasshi       Date:  1992-06

Review 7.  Effects of amrinone on the right side of the heart.

Authors:  W Hess
Journal:  J Cardiothorac Anesth       Date:  1989-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.